Latest Vancomycin Stories
Phase I/II study also demonstrated SER-109 restoration of a diverse, healthy microbiome CAMBRIDGE, Mass., Sept.
Data demonstrate potent, broad spectrum activity against gram-positive and gram-negative bacteria, including resistant organisms that cause skin infections NEW YORK, Sept.
New University of British Columbia research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on.
BAUDETTE, Minn., Aug. 1, 2014 /PRNewswire/ -- ANI Pharmaceuticals, Inc.
To Effectively Compete with Current Anti-MRSA Therapies, Emerging Agents Will Need to be Amenable to Outpatient Use, According to Findings from Decision Resources Group BURLINGTON, Mass., July
LAUSANNE, Switzerland, June 19, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that
As the dangers of the antibiotic-resistant bacteria known as MRSA, in addition to others, become more prevalent due to the overzealous use of antibiotics on livestock farms, Clearstream says that antimicrobial
FIRST® - Vancomycin compounding kits make pharmacy compounding easier WOBURN, Mass., April 30, 2014 /PRNewswire/ -- CutisPharma, Inc.
A pilot study by Massachusetts General Hospital (MGH) investigators may lead to greater availability and acceptability of an unusual treatment for a serious medical problem – use of fecal material from healthy donors to treat recurrent diarrhea caused by the Clostridium difficile (C. difficile) bacteria.
But 19 in 20 patients with a history of penicillin "allergy" are not penicillin allergic ROUND ROCK, Texas, March 10, 2014 /PRNewswire/ -- A new study in the Journal of Allergy and Clinical
Enterococcus is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is a main constituent of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans, especially in the nosocomial environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of...
Enterococcus faecalis "“ formerly classified as part of the Group D Streptococcus system "“ is a Gram-positive, commensal bacterium inhabiting the gastrointestinal tracts of humans and other mammals. It is one of the main constituents of some probiotic food supplements. E. faecalis can cause life-threatening infections in humans. It is frequently found in root canal-treated teeth in prevalence values ranging from 30% to 90% of the cases. It is a non-motile, facultatively anaerobic...
- The governor of a province or people.